Omeros Return on Investment 2009-2019 | OMER

Current and historical return on investment (ROI) values for Omeros (OMER) over the last 10 years.
Omeros ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-06-30 $-0.08B $0.05B -162.81%
2019-03-31 $-0.10B $0.06B -184.75%
2018-12-31 $-0.11B $0.05B -201.80%
2018-09-30 $-0.11B $0.04B -170.75%
2018-06-30 $-0.08B $0.07B -103.31%
2018-03-31 $-0.06B $0.06B -92.19%
2017-12-31 $-0.04B $0.08B -75.86%
2017-09-30 $-0.04B $0.09B -87.05%
2017-06-30 $-0.05B $0.03B -131.54%
2017-03-31 $-0.05B $0.03B -134.27%
2016-12-31 $-0.05B $0.04B -180.00%
2016-09-30 $-0.06B $0.05B -235.29%
2016-06-30 $-0.07B $0.02B -418.75%
2016-03-31 $-0.07B $0.01B -400.00%
2015-12-31 $-0.07B $0.02B -260.55%
2015-09-30 $-0.07B $0.01B -429.41%
2015-06-30 $-0.07B $0.03B -473.33%
2015-03-31 $-0.07B $0.05B -564.71%
2014-12-31 $-0.07B $-0.02B -666.67%
2014-09-30 $-0.06B $0.00B -457.14%
2014-06-30 $-0.06B $0.02B -521.74%
2014-03-31 $-0.06B $0.04B -700.00%
2013-12-31 $-0.05B $-0.00B 10000.00%
2013-09-30 $-0.04B $-0.01B -1173.33%
2013-06-30 $-0.04B $0.01B -567.74%
2013-03-31 $-0.04B $0.00B -1040.00%
2012-12-31 $-0.04B $0.01B -1345.45%
2012-09-30 $-0.04B $0.01B -3120.00%
2012-06-30 $-0.03B $-0.01B -800.00%
2012-03-31 $-0.03B $-0.00B -218.87%
2011-12-31 $-0.03B $0.01B -124.14%
2011-09-30 $-0.03B $0.02B -95.41%
2011-06-30 $-0.03B $0.03B -88.52%
2011-03-31 $-0.03B $0.03B -92.31%
2010-12-31 $-0.03B $0.03B -85.71%
2010-09-30 $-0.03B $0.03B -64.60%
2010-06-30 $-0.02B $0.04B -77.42%
2010-03-31 $-0.02B $0.04B -98.88%
2009-12-31 $-0.02B $0.05B -182.61%
2009-06-30 $-0.02B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.915B $0.030B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 28.00
Medtronic (MDT) Ireland $147.141B 20.65
Stryker (SYK) United States $81.622B 28.23
Boston Scientific (BSX) United States $58.240B 28.25
Baxter (BAX) United States $44.383B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.497B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.496B 18.24
Lonza Group Ag (LZAGY) Switzerland $25.271B 0.00
Coloplast (CLPBY) Denmark $24.948B 39.83
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $20.407B 0.00
ResMed (RMD) United States $18.992B 36.22
Sunny Optical Technology (SNPTF) China $16.672B 0.00
Bio-Rad Laboratories (BIO) United States $9.967B 53.43
Canopy Growth (CGC) Canada $9.552B 0.00
Insulet (PODD) United States $8.633B 511.57
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.024B 20.94
Haemonetics (HAE) United States $6.359B 47.99
Aurora Cannabis (ACB) Canada $6.071B 0.00
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
GW Pharmaceuticals (GWPH) United Kingdom $4.356B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.116B 68.33
NuVasive (NUVA) United States $3.380B 26.95
ICU Medical (ICUI) United States $3.364B 21.82
Hutchison China MediTech (HCM) China $2.903B 0.00
Quidel (QDEL) United States $2.783B 27.64
National Vision Holdings (EYE) United States $2.407B 51.95
Agios Pharmaceuticals (AGIO) United States $2.217B 0.00
Cardiovascular Systems (CSII) United States $1.794B 0.00
Aphria (APHA) $1.687B 0.00
VAREX IMAGING (VREX) United States $1.129B 26.01
AtriCure (ATRC) United States $0.989B 0.00
Lantheus Holdings (LNTH) United States $0.956B 25.12
Phibro Animal Health (PAHC) United States $0.866B 14.08
Eagle Pharmaceuticals (EGRX) United States $0.787B 20.07
NanoString Technologies (NSTG) United States $0.774B 0.00
PetIQ (PETQ) United States $0.751B 17.74
Cerus (CERS) United States $0.747B 0.00
LeMaitre Vascular (LMAT) United States $0.705B 41.80
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.640B 0.00
Surmodics (SRDX) United States $0.632B 120.08
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.468B 21.69
Meridian Bioscience (VIVO) United States $0.422B 13.16
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.409B 0.00
Owens & Minor (OMI) United States $0.394B 11.81
BioLife Solutions (BLFS) United States $0.385B 126.69
Utah Medical Products (UTMD) United States $0.369B 27.00
United Health Products (UEEC) United States $0.325B 0.00
Zynex (ZYXI) United States $0.292B 31.03
Bovie Medical (APYX) United States $0.256B 0.00
Rockwell Medical (RMTI) United States $0.197B 0.00
Cytosorbents (CTSO) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.159B 0.00
Fonar (FONR) United States $0.157B 11.17
Chimerix (CMRX) United States $0.135B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.088B 20.72
MRI Interventions (MRIC) United States $0.065B 0.00
Nephros (NEPH) United States $0.058B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Trinity Biotech (TRIB) Ireland $0.031B 0.00
Senestech (SNES) United States $0.025B 0.00
Myomo (MYO) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00